Cyanomethyl derivatives as cysteine protease inhibitors
申请人:Graupe Michael
公开号:US20060122184A1
公开(公告)日:2006-06-08
The present invention is directed to cyanomethyl derivatives that are inhibitors of cysteine protease, in particular, cathepsin B, K, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
The present invention is directed to compounds that are inhibitors of cysteine protease, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
CYANOMETHYL DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS
申请人:AXYS PHARMACEUTICALS, INC.
公开号:EP1569954A1
公开(公告)日:2005-09-07
[EN] CYANOMETHYL DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS<br/>[FR] DERIVES DE CYANOMETHYLE EN TANT QU'INHIBITEURS DE LA PROTEASE A CYSTEINE
申请人:AXYS PHARM INC
公开号:WO2004052921A1
公开(公告)日:2004-06-24
The present invention is directed to cyanomethyl derivatives that are inhibitors of cysteine protease, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.